Press Releases

These press releases are intended as reference information for U.S. investors and journalists. These press releases correspond to each fiscal quarter ended and should not be deemed accurate or current except as of the date of the particular press release.

Athersys, Inc. has no intention of updating any of the information contained in previously issued press releases and specifically disclaims any duty to update such information. Readers are urged to refer to the most recent press release and SEC filings for the most current information
 

All Releases
Athersys Reports Second Quarter 2018 Results
Aug 7, 2018

Management to host conference call at 4:30pm EDT today CLEVELAND , Aug. 07, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2018 . Highlights of the second quarter of 2018 and recent events include: Announced the

Athersys Makes Important Leadership Hire to Carry Out Its Manufacturing Strategy
Aug 3, 2018

Company Appoints Greg Liposky, MBA as Senior Vice President of Commercial Manufacturing CLEVELAND , Aug. 03, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced the addition of an experienced manufacturing executive to oversee manufacturing operations and help plan for and lead the

Athersys Announces Enrollment of First Patient in Masters-2 Phase 3 Study of Multistem® Treatment for Ischemic Stroke
Jul 31, 2018
Pivotal study has received a Special Protocol Assessment (SPA), Fast Track Designation, and Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ( FDA ) CLEVELAND , July 31, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc.
Athersys to Host Second Quarter Financial Results Call
Jul 10, 2018
CLEVELAND , July 10, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) will release its second quarter 2018 financial results at approximately 4:00 PM Eastern Time on Tuesday, August 7 th , 2018, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. 
Athersys Announces Expansion of Collaboration With Healios
Jun 7, 2018
CLEVELAND, Ohio, June 07, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) announced today that it has entered into an agreement with HEALIOS K.K. (“Healios”) to expand their collaboration into additional therapeutic areas. Under the terms of the agreements, Healios obtained exclusive
Athersys Reports First Quarter 2018 Results
May 10, 2018
Management to host conference call at 4:30pm EDT today
Athersys and Healios Extend by One Month the Period to Complete Collaboration Expansion Agreements
May 1, 2018
CLEVELAND and TOKYO , May 01, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) and HEALIOS K.K . ("Healios") (TSE Mothers Code:4593) have agreed to extend the period from April 30, 2018 to May 31, 2018 to complete their planned collaboration expansion agreements, as defined in the March 13,
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients
Apr 23, 2018
Pioneering Phase 2 study of cell therapy in Trauma to be conducted at major Level 1 Trauma Center in the U.S. with funding from MTEC Grant Award
Athersys to Host First Quarter Financial Results Call
Apr 12, 2018
CLEVELAND , April 12, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018 , and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results.
Athersys to Present at Needham Healthcare Conference on March 28
Mar 20, 2018
CLEVELAND , March 20, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen , Chairman and CEO, will present a corporate overview at the 17 th Annual Needham Healthcare Conference at The Westin Grand Central Hotel in New York City.  The presentation is